Form4insider filings, from the source

SEC Form 4/A · accession 0001209191-18-024834

CONCERT PHARMACEUTICALS, INC. · CNCE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Roger D Tung
Officer — Chief Executive Officer · Director
Period of report
Mar 21, 2018
Accepted (ET)
Apr 13, 2018 · 4:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367920

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Mar 31, 2018F5,890$22.90D598,923D
Common StockF3holding———121,873IBy Roger D. Tung 2011 GRAT
Common StockF4holding———13,274IBy Tung Family Investment Trust
Common StockF5holding———12,389IBy RD Tung Irrevocable Trust

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses